Pharmafile Logo
Pharmafocus logo
Advanced Search

MPs hit out at NHS reforms

January 18, 2011
GP consortia, Health Select Committee, NHS, NHS reforms, PCTs

MPs have come out against the NHS White Paper, saying it has caused wide spread uncertainty at a time when …

News

European Commission launches new generic deal review

January 18, 2011
Sales and Marketing European Commission, anti-trust investigation, competition, generics

The European Commission has asked a number of firms to submit copies of their patent settlements in 2010 to see …

News

GSK takes £2.2bn hit from Avandia claims

January 18, 2011
Sales and Marketing Avandia, GSK, GlaxoSmithKline, rosiglitazone

GlaxoSmithKline’s Avandia woes are continuing, with the company admitting it expects to take a mammoth legal charge over the troubled …

News

Merck Serono and Domain to co-develop Parkinson’s drugs

January 18, 2011
Research and Development Domain Therapeutics, Merck KGaA, Merck Serono, PAM, Parkinson's disease, Parkinson’s disease, Positive Allosteric Modulator, mGluR4, metabotropic glutamate receptor 4

Merck Serono is to work with French biotech company Domain Therapeutics to develop a new treatment for Parkinson’s disease and …

News

Merck suffers late-stage blow to vorapaxar

January 18, 2011
Research and Development ACS, Merck & Co, acute coronary syndrome, anticoagulant, heart attack, peripheral arterial disease, stroke, vorapaxar

An increased risk of bleeding caused by pipeline drug vorapaxar has dealt Merck a major blow.The Data and Safety Monitoring …

News

BMS and Sanofi recall 64 million Avalide tablets

January 18, 2011
Manufacturing and Production Avalide, Avapro, Bristol-Myers Squibb, GMP, Good Manufacturing Practice, Sanofi-Aventis, hypertension, irbesartan

Bristol-Myers Squibb and Sanofi-Aventis have started another massive recall of their antihypertensive product Avalide because a manufacturing defect could affect …

News

Merck taps Parexel to help it meet biosimilar ambitions

January 18, 2011
Research and Development Merck & Co, Parexel, biosimilars

Merck & Co has enlisted the aid of contract research organisation Parexel to help it develop biosimilar versions of some …

News

Top doctors believe PCTs should stay

January 17, 2011
BMA, NHS, NHS reforms, PCTs, Royal College of GP

Leading GPs have criticised the government’s wide-ranging NHS reforms, saying minor structural changes are all the health service needs. A …

News
Sanofi-Aventis' Multaq (dronedarone)

FDA issues Multaq liver warning

January 17, 2011
Sales and Marketing FDA, Multaq, atrial fibrilation, dronedarone

US regulators have warned doctors and patients about the risk of severe liver injury associated with Sanofi-Aventis’ atrial fibrillation (AF) …

News
Blog footer

Digital Pharma: Sanofi launches diabetes blog

January 17, 2011
Medical Communications, Sales and Marketing Digital Pharma blog, Sanofi-Aventis, blog, diabetes

Sanofi-Aventis has ramped up its social media efforts with the launch of a blog about diabetes for US consumers. The …

News

Shire says new plant will add to Replagal, Vpriv capacity

January 17, 2011
Manufacturing and Production Cerezyme, Replagal, Shire, Vpriv

UK drugmaker Shire has completed construction of a new manufacturing facility for its orphan disease drugs Replagal and Vpriv, and …

News

Roche finance chief steps down

January 17, 2011
Sales and Marketing Alan Hippe, Erich Hunziker, Roche, appointment, sales and marketing

Roche’s chief financial officer Erich Hunziker is to retire at the end of March after ten years with the company. …

Appointment
Novo Nordisk's Victoza

Diabetes drugs show promise in Alzheimer’s

January 17, 2011
Research and Development Alzheimer's, Alzheimer’s, Byetta, Novo Nordisk, Victoza, diabetes, exenatide, lilly, liraglutide

Research suggests that new diabetes drugs enhance cell growth in the brain, and could help treat Alzheimer’s disease. Researchers at …

News
Blog footer

Digital Pharma: NHS thrombosis e-learning

January 14, 2011
Medical Communications Bayer, Boehringer Ingelheim, Digital Pharma blog, NHS training, Pfizer, Sanofi-Aventis, VTE, e-learning, venous thromboembolism

The NHS has launched a best-practice website to help educate healthcare professionals about one of the most common causes of …

News

Gates Foundation funds TB drug discovery

January 14, 2011
Research and Development Bill and Melinda Gates Foundation, IDRI, Infectious Disease Research Institute, Lilly TB Drug Discovery Initiative, TB, lilly, tuberculosis

Research to identify leads and drug targets for new tuberculosis treatments is to be funded by the Bill and Melinda …

News

GSK moves Crohn’s disease drug into phase III

January 14, 2011
Research and Development ChemoCentryx, Crohn’s disease, GSK’786, GlaxoSmithKline, Traficet-EN

GlaxoSmithKline and its partner ChemoCentryx have started late-stage trials of GSK’786 for Crohn’s disease. The initial study is a randomised, …

News

Publicis acquires French comms agency

January 14, 2011
Medical Communications Digital District, François Sarkozy, Healthcare Consulting, In-Sync, Publicis Healthcare Consulting, Resolute Communications, Yannick Sabatin, publicis

Paris-based communications giant Publicis Groupe has bought a health comms agency set up by the brother of French president Nicolas …

News

Anti-cancer stem cell drug starts clinical trials

January 14, 2011
Research and Development Cancer, GSK, GlaxoSmithKline, OMP-21M18, OMP-59R5, OncoMed, Stem cells, advanced solid tumour cancers

OncoMed and GSK’s novel anti cancer stem cell drug OMP-59R5 has begun clinical trials and could represent the future direction …

News

Red Health boosts account team

January 14, 2011
Medical Communications Jo Tubbs, Nicole Tripney, appointment, medical communications, red consultancy, red health

The Red Consultancy has started the year with two new hires for its specialist health team, Red Health. Account director …

Appointment
GSK's UK headquarters

End of the line for GSK’s resveratrol

January 14, 2011
Research and Development GSK, GlaxoSmithKline, SRT2104, SRT2379, SRT501, Sirtris, multiple myeloma, resveratrol

GlaxoSmithKline is halting all work on resveratrol, a compound found in red wine and thought to have life extending properties. …

News
The Gateway to Local Adoption Series

Latest content

Could targeting the molecular causes of infertility finally transform IVF success rates?

January 29, 2026

Digital mental health technologies – a valuable tool in supporting people with depression and anxiety

January 29, 2026

Barts Health NHS Trust collaborates with H.I.G. Realty on healthcare innovation building

January 29, 2026

Rentschler Biopharma appoints Detra Glinatsis as Head of Business Development US

January 29, 2026

Five Facts about spinal muscular atrophy

January 28, 2026